CN Patent

CN116670135A — 吡啶酮多并环类衍生物及其应用

Assigned to Huinuo Biomedical Technology Hangzhou Co ltd · Expires 2023-08-29 · 3y expired

What this patent protects

提供了一类吡啶酮多并环类衍生物及其应用，具体公开了式(VI)所示化合物及其药学上可接受的盐。

USPTO Abstract

提供了一类吡啶酮多并环类衍生物及其应用，具体公开了式(VI)所示化合物及其药学上可接受的盐。

Drugs covered by this patent

Xofluza (BALOXAVIR MARBOXIL) · Roche

Patent Metadata

Patent number: CN116670135A
Jurisdiction: CN
Classification: —
Expires: 2023-08-29
Drug substance claim: No
Drug product claim: No
Assignee: Huinuo Biomedical Technology Hangzhou Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.